(S)-3-Bromo-5-iodo-2-(1-methoxyethyl)pyridine, 98%, 1g

2-(4-Fluorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl]acetic acid, 250mg

tert-Butyl 3,6,9,12-tetraoxapentadec-14-yn-1-ylcarbamate, 95%, 100mg

(2-((Tetrahydro-2h-pyran-2-yl)oxy)phenyl)boronic acid, 98%, 1g

2-Cyano-N-(4-fluoro-phenyl)-acetamide, 97.0%, 25g

(4R,4'R)-2,2'-(Propane-2,2-diyl)bis(4-benzyl-4,5-dihydrooxazole), 95.0%, 1g

1-Pentadecene, 95.0%, 1g

6-Bromo-4-fluoroindolin-2-one, 97%, 250mg

5-(2-Thioxo-2,3-dihydrothiazol-4-yl)thiophene-2-carboxamide, 95.0%, 25mg

4,6-Bis(difluoromethoxy)-2-(methylthio)pyrimidine, 98%, 1g

1-(5-Bromo-2-iodophenyl)ethanone, 95+%, 100g

Ethyl 2,4-Dimethylpyrrole-3-carboxylate>98.0%(GC)5g

1,2-Dicloroetano, mínimo 99 %, para síntesis, 2,5 L, envase de vidrio